BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 31487205)

  • 1. Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
    Noyes PD; Friedman KP; Browne P; Haselman JT; Gilbert ME; Hornung MW; Barone S; Crofton KM; Laws SC; Stoker TE; Simmons SO; Tietge JE; Degitz SJ
    Environ Health Perspect; 2019 Sep; 127(9):95001. PubMed ID: 31487205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward an AOP Network-Based Tiered Testing Strategy for the Assessment of Thyroid Hormone Disruption.
    Knapen D; Stinckens E; Cavallin JE; Ankley GT; Holbech H; Villeneuve DL; Vergauwen L
    Environ Sci Technol; 2020 Jul; 54(14):8491-8499. PubMed ID: 32584560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental chemicals impacting the thyroid: targets and consequences.
    Zoeller RT
    Thyroid; 2007 Sep; 17(9):811-7. PubMed ID: 17956155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AOP Report: Thyroperoxidase Inhibition Leading to Altered Visual Function in Fish Via Altered Retinal Layer Structure.
    Gölz L; Baumann L; Pannetier P; Braunbeck T; Knapen D; Vergauwen L
    Environ Toxicol Chem; 2022 Nov; 41(11):2632-2648. PubMed ID: 35942927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenol and Phthalate Effects on Thyroid Hormone Levels during Pregnancy: Relying on
    Nakiwala D; Noyes PD; Faure P; Chovelon B; Corne C; Gauchez AS; Guergour D; Lyon-Caen S; Sakhi AK; Sabaredzovic A; Thomsen C; Pin I; Slama R; Philippat C
    Environ Health Perspect; 2022 Nov; 130(11):117004. PubMed ID: 36350136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid disrupting chemicals and developmental neurotoxicity - New tools and approaches to evaluate hormone action.
    O'Shaughnessy KL; Gilbert ME
    Mol Cell Endocrinol; 2020 Dec; 518():110663. PubMed ID: 31760043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.
    Miller MD; Crofton KM; Rice DC; Zoeller RT
    Environ Health Perspect; 2009 Jul; 117(7):1033-41. PubMed ID: 19654909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
    Murk AJ; Rijntjes E; Blaauboer BJ; Clewell R; Crofton KM; Dingemans MM; Furlow JD; Kavlock R; Köhrle J; Opitz R; Traas T; Visser TJ; Xia M; Gutleb AC
    Toxicol In Vitro; 2013 Jun; 27(4):1320-46. PubMed ID: 23453986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing uncertainties in quantitative adverse outcome pathways by analysis of thyroid hormone in the neonatal rat brain.
    Ford J; Riutta C; Kosian PA; O'Shaughessy K; Gilbert M
    Toxicol Sci; 2023 May; 193(2):192-203. PubMed ID: 37099719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal effects of persistent organic pollutants on thyroid hormone concentration in placenta and breastmilk.
    De Angelis M; Schramm KW
    Mol Aspects Med; 2022 Oct; 87():100988. PubMed ID: 34238594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-tiered, in vivo, quantitative assay suite for environmental disruptors of thyroid hormone signaling.
    Mengeling BJ; Wei Y; Dobrawa LN; Streekstra M; Louisse J; Singh V; Singh L; Lein PJ; Wulff H; Murk AJ; Furlow JD
    Aquat Toxicol; 2017 Sep; 190():1-10. PubMed ID: 28662416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approach methods to improve human health risk assessment of thyroid hormone system disruption-a PARC project.
    Ramhøj L; Axelstad M; Baert Y; Cañas-Portilla AI; Chalmel F; Dahmen L; De La Vieja A; Evrard B; Haigis AC; Hamers T; Heikamp K; Holbech H; Iglesias-Hernandez P; Knapen D; Marchandise L; Morthorst JE; Nikolov NG; Nissen ACVE; Oelgeschlaeger M; Renko K; Rogiers V; Schüürmann G; Stinckens E; Stub MH; Torres-Ruiz M; Van Duursen M; Vanhaecke T; Vergauwen L; Wedebye EB; Svingen T
    Front Toxicol; 2023; 5():1189303. PubMed ID: 37265663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
    Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
    ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences.
    Gilbert ME; Rovet J; Chen Z; Koibuchi N
    Neurotoxicology; 2012 Aug; 33(4):842-52. PubMed ID: 22138353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?
    Marty S; Beekhuijzen M; Charlton A; Hallmark N; Hannas BR; Jacobi S; Melching-Kollmuss S; Sauer UG; Sheets LP; Strauss V; Urbisch D; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2021 Apr; 51(4):328-358. PubMed ID: 34074207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
    Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child thyroid disruption by environmental chemicals.
    Massart F; Massai G; Placidi G; Saggese G
    Minerva Pediatr; 2006 Feb; 58(1):47-53. PubMed ID: 16541006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone action in fetal brain development and potential for disruption by environmental chemicals.
    Zoeller RT; Crofton KM
    Neurotoxicology; 2000 Dec; 21(6):935-45. PubMed ID: 11233763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clues from wildlife to create an assay for thyroid system disruption.
    Colborn T
    Environ Health Perspect; 2002 Jun; 110 Suppl 3(Suppl 3):363-7. PubMed ID: 12060830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
    Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
    Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.